Search
for
Sort by
Research 421–450 of 1000+
- Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?
- Gender-Affirming Hormone Therapy for Transgender Men
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- The role of androgens in hormone replacement therapy
- Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
- Influence of Saw palmetto and Pygeum africana extracts on the urinary concentrations of endogenous anabolic steroids: Relevance to doping analysis
- Prospective metabolic evaluation of 150 consecutive patients who underwent gastric exclusion
- ARTIFICIAL INTELLIGENCE AND THE DIAGNOSTIC INVISIBILITY OF WOMEN’S METABOLIC DISORDERS: A NARRATIVE REVIEW OF SOCIO-TECHNICAL CHALLENGES IN PCOS/PMOS RECOGNITION
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- A Review of hormone-based therapies to treat adult acne vulgaris in women
- Insulin resistance and metabolic syndrome in female androgenetic alopecia
- Adrenal steroid precursors exert potent androgenic action in the hamster sebaceous glands of flank organs and ears.
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- Metabolic risk in PCOS: phenotype and adiposity impact
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Anabolic-androgenic steroids. Mechanism of action and clinical effects
- Metabolic Syndrome in Androgenetic Alopecia in a Tertiary Care Centre in Goa: A Case Control Study During COVID-19 Pandemic
- Hepatotoxicity Associated with Anabolic Androgenic Steroids and Selective Androgen Receptor Modulators: A Literature Review
- Elevated serum chromogranin A levels are independently associated with metabolic and inflammatory disturbances in polycystic ovary syndrome
- Metabolic Aspects of Polycystic Ovary Syndrome
- Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study
- Is Prenatal Sex Hormone Balance a Risk Factor for the Development of Hidradenitis Suppurativa
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Comparison of metformin and N-acetylcysteine on metabolic parameters in women with polycystic ovarian syndrome
- Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients
- Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism
- Effects of Oral Contraceptives Containing Desogestrel and Drospirenone on Clinical, Hormonal, and Metabolic Parameters of the Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial